Clinical Trials

Title   [891570-4] A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women
Description   This study seeks to evaluate the efficacy, safety and tolerability of elagolix alone and in combination with estradiol/norethindrone acetate for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
IRB Number   16-127
Treatment   Uterine Fibroids
Status   Active
Principal Name   Botros Rizk, M.D.
Contact Name   Casey Armistead

Email Newsletters

Connect With Us